Br J Haematol 2014 Oct 3;167(1):133-6. Epub 2014 May 3.
Department of Diagnostic, Clinical, and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy.
Virchows Arch 2021 Jan 19;478(1):137-150. Epub 2021 Feb 19.
Pathology, Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland.
The lung is the main affected organ in severe coronavirus disease 2019 (COVID-19) caused by the novel coronavirus SARS-CoV-2, and lung damage is the leading cause of death in the vast majority of patients. Mainly based on results obtained by autopsies, the seminal features of fatal COVID-19 have been described by many groups worldwide. Early changes encompass edema, epithelial damage, and capillaritis/endothelialitis, frequently combined with microthrombosis. Read More
Clin Exp Emerg Med 2020 Dec 31;7(4):326-329. Epub 2020 Dec 31.
Department of Emergency Medicine, Faculty of Medicine, Mersin University, Mersin, Turkey.
A 25-year-old man presented to the emergency department with acute-onset chest pain and shortness of breath. A physical examination revealed coarse crackles in the both lower lungs. Consolidation and ground-glass opacities suggesting viral infection were detected in the right lower lobe on chest computed tomography. Read More
Acta Haematol 2020 Dec 3:1-11. Epub 2020 Dec 3.
Clinical Trial Center, Pusan National University Hospital, Busan, Republic of Korea.
Introduction: The effects of lymphocyte subtypes, including helper (Th), natural killer (NK), and regulatory (Treg) cells, and other T-cell subtypes on treatment outcomes in diffuse large B-cell lymphoma (DLBCL) patients are not clearly established.Methods: Among 151 consecutive patients diagnosed with DLBCL, we collected peripheral blood samples at diagnosis from 91 patients who received at least 1 cycle of R-CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab) chemotherapy and analyzed lymphocyte subsets by flow cytometry.Results: DLBCL patients had a higher proportion of CD4+CD25+ Treg (p < 0. Read More
Sarcoidosis Vasc Diffuse Lung Dis 2020 30;37(2):87-98. Epub 2020 Jun 30.
Division of Pulmonary, Critical Care, Sleep, and Allergy, University of Illinois at Chicago, Chicago, IL, USA.
Sarcoidosis is a systemic inflammatory disease characterized by granuloma formation in affected organs and caused by dysregulated immune response to an unknown antigen. Sarcoidosis patients receiving immunosuppressive medications are at increased risk of infection. Lymphopenia is also commonly seen among patient with sarcoidosis. Read More
Spinal Cord Ser Cases 2020 09 30;6(1):92. Epub 2020 Sep 30.
Unipolar Spinal Unit and Neurourology Service, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Introduction: We observed individuals affected by spinal cord dysfunction (SCD) after coronavirus disease 2019 (COVID-19). The aim of our report is to provide our initial experience with individuals experiencing SCD after COVID-19 in a referral center in Northern Italy, from February 21 to July 15, 2020.Case Presentation: We report on three men with SCD after COVID-19. Read More